| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |